The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Mucins in pancreatic cancer and its microenvironment
Open accessAbstract
Pancreatic cancer remains a lethal malignancy with poor prognosis owing to therapeutic resistance, frequent recurrence and the absence of treatment strategies that specifically target the tumour and its supporting stroma. Deregulated cell-surface proteins drive neoplastic transformations and are envisioned to mediate crosstalk between the tumour and its microenvironment. Emerging studies have elaborated on the role of mucins in diverse biological functions, including enhanced tumorigenicity, invasiveness, metastasis and drug resistance through their characteristic O-linked and N-linked oligosaccharides (glycans), extended structures and unique domains. Multiple mucin domains differentially interact and regulate different components of the tumour microenvironment. This Review discusses: the expression pattern of various mucins in the pancreas under healthy, inflammatory, and cancerous conditions; the context-dependent attributes of mucins that differ under healthy and pathological conditions; the contribution of the tumour microenvironment in pancreatic cancer development and/or progression; diagnostic and/or prognostic efficacy of mucins; and mucin-based therapeutic strategies. Overall, this information should help to delineate the intricacies of pancreatic cancer by exploring the family of mucins, which, through various mechanisms in both tumour cells and the microenvironment, worsen disease outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Wiederschain, G. Y. (2009) · Biochemistry (Moscow) · doi:10.1134/s0006297909090156 · Cited by 4,083
Varki, A. P., Cummings, R. D., Esko, J. D., Freeze, H. H., Stanley, P., Bertozzi, C. R., Hart, G. W., & Etzler, M. E. (1999) · Cited by 2,384
Mucins in cancer: protection and control of the cell surface
Hollingsworth, M. A., & Swanson, B. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1251 · Cited by 1,807
Mucins in cancer: function, prognosis and therapy
Kufe, D. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2761 · Cited by 1,396
The Pancreas Cancer Microenvironment
Feig, C., Gopinathan, A., Neesse, A., Chan, D. S., Cook, N., & Tuveson, D. A. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3114 · Cited by 1,316
T and Tn, General Carcinoma Autoantigens
Springer, G. F. (1984) · Science · doi:10.1126/science.6729450 · Cited by 1,009
Varki, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7390 · Cited by 946
Goonetilleke, K. S., & Siriwardena, A. K. (2007) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2006.10.004 · Cited by 877
Ballehaninna, U. K., & Chamberlain, R. S. (2012) · PubMed · doi:10.3978/j.issn.2078-6891.2011.021 · Cited by 701
Cell surface-associated mucins in signal transduction
Singh, P. K., & Hollingsworth, M. A. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.07.006 · Cited by 422
Structural organization and classification of the human mucin genes
Moniaux, N. (2001) · Frontiers in Bioscience · doi:10.2741/moniaux · Cited by 387
Bafna, S., Kaur, S., & Batra, S. K. (2010) · Oncogene · doi:10.1038/onc.2010.87 · Cited by 360
Self-citationGolgi localization of glycosyltransferases: more questions than answers
Colley, K. J. (1997) · Glycobiology · doi:10.1093/glycob/7.1.1-b · Cited by 321
Gel-forming mucins appeared early in metazoan evolution
Lang, T., Hansson, G. C., & Samuelsson, T. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705984104 · Cited by 315
Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer
Savla, R., Taratula, O., Garbuzenko, O., & Minko, T. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.02.015 · Cited by 314
Ni, X. G., Bai, X. F., Mao, Y. L., Shao, Y. F., Wu, J. X., Shan, Y., Wang, C. F., Wang, J., Tian, Y. T., Liu, Q., et al. (2005) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2004.09.007 · Cited by 303
Yu, L.-G., Andrews, N., Zhao, Q., McKean, D., Williams, J. F., Connor, L. J., Gerasimenko, O. V., Hilkens, J., Hirabayashi, J., Kasai, K., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606862200 · Cited by 303
A Phase I Trial of a Synthetic Mucin Peptide Vaccine
Goydos, J. S., Elder, E., Whiteside, T. L., Finn, O. J., & Lotze, M. T. (1996) · Journal of Surgical Research · doi:10.1006/jsre.1996.0264 · Cited by 275
Karanikas, V, Hwang, L. A., Pearson, J., Ong, C. S., Apostolopoulos, V, Vaughan, H., Xing, P. X., Jamieson, G., Pietersz, G., Tait, B., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119825 · Cited by 263
Integrin Clustering Is Driven by Mechanical Resistance from the Glycocalyx and the Substrate
Paszek, M. J., Boettiger, D., Weaver, V. M., & Hammer, D. A. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000604 · Cited by 257
Andrianifahanana, M., Moniaux, N., Schmied, B. M., Ringel, J., Friess, H., Hollingsworth, M. A., Büchler, M., Aubert, J., & Batra, S. K. (2001) · PubMed · Cited by 254
Self-citationStructure, evolution, and biology of the MUC4 mucin
Chaturvedi, P., Singh, A. P., & Batra, S. K. (2008) · The FASEB Journal · doi:10.1096/fj.07-9673rev · Cited by 252
Self-citationMUC4 Expression Increases Progressively in Pancreatic Intraepithelial Neoplasia
Swartz, M. J., Batra, S. K., Varshney, G. C., Hollingsworth, M. A., Yeo, C. J., Cameron, J. L., Wilentz, R. E., Hruban, R. H., & Argani, P. (2002) · American Journal of Clinical Pathology · doi:10.1309/7y7n-m1wm-r0yk-m2va · Cited by 241
Self-citationProfiling Tumor-Associated Antibodies for Early Detection of Non-small Cell Lung Cancer
Zhong, L., Coe, S. P., Stromberg, A. J., Khattar, N. H., Jett, J. R., & Hirschowitz, E. A. (2006) · Journal of Thoracic Oncology · doi:10.1016/s1556-0864(15)30352-x · Cited by 238
Characterization of the Oligosaccharides Associated with the Human Ovarian Tumor Marker CA125
Kui Wong, N., Easton, R. L., Panico, M., Sutton-Smith, M., Morrison, J. C., Lattanzio, F. A., Morris, H. R., Clark, G. F., Dell, A., & Patankar, M. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302741200 · Cited by 238
Inhibition of MUC4 Expression Suppresses Pancreatic Tumor Cell Growth and Metastasis
Singh, A. P., Moniaux, N., Chauhan, S. C., Meza, J. L., & Batra, S. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2636 · Cited by 229
Self-citationChaika, N. V., Gebregiworgis, T., Lewallen, M. E., Purohit, V., Radhakrishnan, P., Liu, X., Zhang, B., Mehla, K., Brown, R. B., Caffrey, T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203339109 · Cited by 227
Pancreatic cancer microenvironment
Kleeff, J., Beckhove, P., Esposito, I., Herzig, S., Huber, P. E., Löhr, J. M., & Friess, H. (2007) · International Journal of Cancer · doi:10.1002/ijc.22871 · Cited by 225
Early Diagnosis of Pancreatic Cancer: Challenges and New Developments
Kaur, S., Baine, M. J., Jain, M., Sasson, A. R., & Batra, S. K. (2012) · Biomarkers in Medicine · doi:10.2217/bmm.12.69 · Cited by 220
Self-citationRamanathan, R. K., Lee, K. M., McKolanis, J., Hitbold, E., Schraut, W., Moser, A. J., Warnick, E., Whiteside, T., Osborne, J., Kim, H., et al. (2005) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-004-0581-1 · Cited by 217
Molecular markers of early pancreatic cancer
Goggins, M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.19.711 · Cited by 214
Price‐Schiavi, S. A., Jepson, S., Li, P., Arango, M., Rudland, P. S., Yee, L., & Carraway, K. L. (2002) · International Journal of Cancer · doi:10.1002/ijc.10410 · Cited by 209
Zhao, Q., Barclay, M., Hilkens, J., Guo, X., Barrow, H., Rhodes, J. M., & Yu, L.-G. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-154 · Cited by 209
Tewes, M., Aktas, B., Welt, A., Mueller, S., Hauch, S., Kimmig, R., & Kasimir-Bauer, S. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0143-x · Cited by 203
Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model.
Rowse, G. J., Tempero, R. M., VanLith, M. L., Hollingsworth, M. A., & Gendler, S. J. (1998) · PubMed · Cited by 202
Lepisto, A. J., Moser, A. J., Zeh, H. J., Lee, K., Bartlett, D. L., McKolanis, J., Geller, B. A., Schmotzer, A. R., Potter, D. P., Whiteside, T. L., et al. (2008) · PubMed · Cited by 189
Remmers, N. A., Anderson, J. M., Linde, E. M., DiMaio, D. J., Lazenby, A. J., Wandall, H. H., Mandel, U., Clausen, H., Yu, F., & Hollingsworth, M. A. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2662 · Cited by 188
Occurrence of Autoantibodies to Annexin I, 14-3-3 Theta and LAMR1 in Prediagnostic Lung Cancer Sera
Qiu, J., Choi, G., Li, L., Wang, H., Pitteri, S. J., Pereira-Faca, S. R., Krasnoselsky, A. L., Randolph, T. W., Omenn, G. S., Edelstein, C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.2388 · Cited by 184
Chaturvedi, P., Singh, A. P., Moniaux, N., Senapati, S., Chakraborty, S., Meza, J. L., & Batra, S. K. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0353 · Cited by 176
Self-citationOregovomab Maintenance Monoimmunotherapy Does Not Improve Outcomes in Advanced Ovarian Cancer
Berek, J., Taylor, P., McGuire, W., Smith, L. M., Schultes, B., & Nicodemus, C. F. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.8400 · Cited by 172
Allavena, P., Chieppa, M., Bianchi, G., Solinas, G., Fabbri, M., Laskarin, G., & Mantovani, A. (2010) · Journal of Immunology Research · doi:10.1155/2010/547179 · Cited by 170
Mucin expression profile in pancreatic cancer and the precursor lesions
Nagata, K., Horinouchi, M., Saitou, M., Higashi, M., Nomoto, M., Goto, M., & Yonezawa, S. (2007) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-006-1169-2 · Cited by 168
Strobel, O., Rosow, D. E., Rakhlin, E. Y., Lauwers, G. Y., Trainor, A. G., Alsina, J., Fernández–Del Castillo, C., Warshaw, A. L., & Thayer, S. P. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.005 · Cited by 168
Detection of sialomucin complex (MUC4) in human ocular surface epithelium and tear fluid.
Pflugfelder, S. C., Liu, Z., Monroy, D. C., Li, D., Carvajal, M. E., Price‐Schiavi, S. A., Idris, N., Solomon, A., Perez, A., & Carraway, K. L. (2000) · PubMed · Cited by 164
MUC4 Mucin Interacts with and Stabilizes the HER2 Oncoprotein in Human Pancreatic Cancer Cells
Chaturvedi, P., Singh, A. P., Chakraborty, S., Chauhan, S. C., Bafna, S., Meza, J. L., Singh, P. K., Hollingsworth, M. A., Mehta, P. P., & Batra, S. K. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6041 · Cited by 163
Self-citationA novel strategy for evasion of NK cell immunity by tumours expressing core2 O‐glycans
Tsuboi, S., Sutoh, M., Hatakeyama, S., Hiraoka, N., Habuchi, T., Horikawa, Y., Hashimoto, Y., Yoneyama, T., Mori, K., Koie, T., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.215 · Cited by 162
Mucin gene (MUC1) transfected dendritic cells as vaccine: results of a phase I/II clinical trial
Pecher, G., Häring, A., Kaiser, L., & Thiel, E. (2002) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-002-0317-z · Cited by 159
Raina, D. B., Ahmad, R., Joshi, M. D., Li, Y., Wu, Z., Kawano, T., Vasir, B., Avigan, D., Kharbanda, S. M., & Kufe, D. W. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0854 · Cited by 153
Higuchi, T., Orita, T., Nakanishi, S., Katsuya, K., Watanabe, H., Yamasaki, Y., Waga, I., Nanayama, T., Yamamoto, Y., Munger, W. E., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m304558200 · Cited by 153
Kohlgraf, K. G., Gawron, A. J., Higashi, M., Meza, J. L., Burdick, M. D., Kitajima, S., Kelly, D. L., Caffrey, T. C., & Hollingsworth, M. A. (2003) · PubMed · Cited by 149
SAITOU, M., Goto, M., Horinouchi, M., Tamada, S., Nagata, K., Hamada, T., Osako, M., Takao, S., Batra, S. K., Aikou, T., et al. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2004.023572 · Cited by 145
Self-citationPathobiological Implications of MUC16 Expression in Pancreatic Cancer
Haridas, D., Chakraborty, S., Ponnusamy, M. P., Lakshmanan, I., Rachagani, S., Cruz, E., Sushil Kumar, K., Das, S., Lele, S. M., Anderson, J. M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026839 · Cited by 144
Self-citationNath, Hartnell, Happerfield, Miles, Burchell, J., Taylor‐Papadimitriou, & Crocker, P. R. (1999) · Immunology · doi:10.1046/j.1365-2567.1999.00827.x · Cited by 142
Localization of Golgi-resident glycosyltransferases
Tu, L., & Banfield, D. K. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0126-z · Cited by 138
Seromic profiling of colorectal cancer patients with novel glycopeptide microarray
Pedersen, J. W., Blixt, O., Bennett, E., Tarp, M. A., Dar, I., Mandel, U., Poulsen, S. S., Pedersen, A. E., Rasmussen, S. B., Jess, P., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25778 · Cited by 136
MUC1 regulates nuclear localization and function of the epidermal growth factor receptor
Bitler, B. G., Goverdhan, A., & Schroeder, J. A. (2010) · Journal of Cell Science · doi:10.1242/jcs.062661 · Cited by 136
Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview
Bünger, S., Laubert, T., Roblick, U. J., & Habermann, J. K. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0965-x · Cited by 135
Jhala, N. C., Jhala, D. N., Vickers, S. M., Eltoum, I. A., Batra, S. K., Manne, U., Eloubeidi, M. A., Jones, J. J., & Grizzle, W. E. (2006) · American Journal of Clinical Pathology · doi:10.1309/cev30be088cbdqd9 · Cited by 135
Self-citationSoares, M., Mehta, V., & Finn, O. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6555 · Cited by 135
Komatsu, M., Yee, L., & Carraway, K. L. (1999) · PubMed · Cited by 135
Besmer, D. M., Curry, J. M., Roy, L. D., Tinder, T. L., Sahraei, M., Schettini, J. L., Hwang, S., Lee, Y. Y., Gendler, S. J., & Mukherjee, P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4439 · Cited by 132
Yue, T., Goldstein, I. J., Hollingsworth, M. A., Kaul, K. L., Brand, R. E., & Haab, B. B. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900135-mcp200 · Cited by 132
Swanson, B. J., McDermott, K. M., Singh, P. K., Eggers, J. P., Crocker, P. R., & Hollingsworth, M. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2483 · Cited by 128
Yonezawa, S., Horinouchi, M., Osako, M., 久保, 昌., Takao, S., Arimura, Y., Nagata, K., Tanaka, S., Sakoda, K., Aikou, T., et al. (1999) · Pathology International · doi:10.1046/j.1440-1827.1999.00823.x · Cited by 126
Mucin gene expression in intraductal papillary‐mucinous pancreatic tumours and related lesions
Terris, B., Dubois, S., Buisine, M., Sauvanet, A., Ruszniewski, P. B., Aubert, J., Porchet, N., Couvelard, A., Degott, C., & Fléjou, J. (2002) · The Journal of Pathology · doi:10.1002/path.1146 · Cited by 121
Identification and Expression of Human Epiglycanin/MUC21: a Novel Transmembrane Mucin
Yasuaki, I. T. O. H., Kamata‐Sakurai, M., Denda‐Nagai, K., et al. (2007) · Glycobiology · doi:10.1093/glycob/cwm118 · Cited by 119
MUC1 peptide vaccination in patients with advanced pancreas or biliary tract cancer.
Yamamoto, K. T., Ueno, T., Kawaoka, T., Hazama, S., Fukui, M., Suehiro, Y., Hamanaka, Y., Ikematsu, Y., Imai, K., Oka, M., et al. (2005) · PubMed · Cited by 117
Poxvirus-based vaccine therapy for patients with advanced pancreatic cancer
Kaufman, H. L., Kim‐Schulze, S., Manson, K. H., DeRaffele, G., Mitcham, J., Seo, K.-S., Kim, D. W., & Marshall, J. L. (2007) · Journal of Translational Medicine · doi:10.1186/1479-5876-5-60 · Cited by 116
Distinct evolution of the human carcinoma-associated transmembrane mucins, MUC1, MUC4 AND MUC16
Duraisamy, S., Ramasamy, S., Kharbanda, S. M., & Kufe, D. W. (2006) · Gene · doi:10.1016/j.gene.2005.12.021 · Cited by 115
Tsutsumida, H., Swanson, B. J., Singh, P. K., Caffrey, T. C., Kitajima, S., Goto, M., Yonezawa, S., & Hollingsworth, M. A. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1197 · Cited by 115
Shimizu, A., Hirono, S., Tani, M., Kawai, M., Okada, K., Miyazawa, M., Kitahata, Y., Nakamura, Y., Noda, T., Yokoyama, S., et al. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02214.x · Cited by 114
Kondo, H., Hazama, S., Kawaoka, T., Yoshino, S., Yoshida, S., Tokuno, K., 高島, 元., Ueno, T., Hinoda, Y., & Oka, M. (2008) · PubMed · Cited by 110
MUC13 Mucin Augments Pancreatic Tumorigenesis
Chauhan, S. C., Ebeling, M. C., Maher, D. M., Koch, M. D., Watanabe, A., Aburatani, H., Lio, Y., & Jaggi, M. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0598 · Cited by 109
Tinder, T. L., Subramani, D. B., Basu, G. D., Bradley, J. M., Schettini, J. L., Arefayene, M., Skaar, T. C., & Mukherjee, P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3116 · Cited by 108
Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer
Singh, A. P., Senapati, S., Ponnusamy, M. P., Jain, M. R., Lele, S. M., Davis, J. S., Remmenga, S. W., & Batra, S. K. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70277-8 · Cited by 104
Self-citationYonezawa, S., Sueyoshi, K., Nomoto, M., Kitamura, H., Nagata, K., Arimura, Y., Tanaka, S., Hollingsworth, M. A., Siddiki, B., Kim, Y. S., et al. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90134-9 · Cited by 101
Park, H., Kim, J., Kim, G., Bae, H., Crawley, S., Yang, S. C., Gum, J. R., Batra, S. K., Rousseau, K., Swallow, D. M., et al. (2003) · Pancreas · doi:10.1097/00006676-200304000-00022 · Cited by 101
Self-citationMUC1 Oncoprotein Functions in Activation of Fibroblast Growth Factor Receptor Signaling
Ren, J., Raina, D. B., Chen, W., Li, G., Huang, L. H., & Kufe, D. W. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0204 · Cited by 97
Precursor Lesions of Pancreatic Cancer
Yonezawa, S., Higashi, M., Yamada, N., & Goto, M. (2008) · Gut and Liver · doi:10.5009/gnl.2008.2.3.137 · Cited by 95
Regulation of Sialyl Lewis Antigen Expression in Colon Cancer Cells by Sialidase NEU4
Shiozaki, K., Yamaguchi, K., Takahashi, K., Moriya, S., & Miyagi, T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.231191 · Cited by 94
Li, Y., Yu, W., Ren, J., Chen, W., Huang, L. H., Kharbanda, S. M., Loda, M. F., & Kufe, D. W. (2003) · PubMed · Cited by 94
Phosphorylation of MUC1 by Met Modulates Interaction with p53 and MMP1 Expression
Singh, P. K., Behrens, M. E., Eggers, J. P., Cerny, R. L., Bailey, J. M., Shanmugam, K., Gendler, S. J., Bennett, E., & Hollingsworth, M. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805036200 · Cited by 90
MUC‐1 mucin expression in invasive areas of intraductal papillary mucinous tumors of the pancreas
Yonezawa, S., TAIRA, M., Osako, M., 久保, 昌., Tanaka, S., Sakoda, K., Takao, S., Aiko, T., Yamamoto, M., LRIMURA, T., et al. (1998) · Pathology International · doi:10.1111/j.1440-1827.1998.tb03913.x · Cited by 89
Funes, M., Miller, J. K., Lai, C., Carraway, K. L., & Sweeney, C. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603225200 · Cited by 88
MUC1 enhances hypoxia-driven angiogenesis through the regulation of multiple proangiogenic factors
Kitamoto, S., Yokoyama, S., Higashi, M., Yamada, N., Takao, S., & Yonezawa, S. (2012) · Oncogene · doi:10.1038/onc.2012.478 · Cited by 85
Lee, S. H., Hatakeyama, S., Yu, S., Bao, X., Οhyama, C., Khoo, K., Fukuda, M. N., & Fukuda, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.010934 · Cited by 84
Intracellular MUC1 Peptides Inhibit Cancer Progression
Bitler, B. G., Menzl, I., Huerta, C. L., Sands, B., Knowlton, W., Chang, A. C., & Schroeder, J. A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1745 · Cited by 84
Tsuboi, S. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1411 · Cited by 84
Yue, T., Maupin, K. A., Fallon, B. P., Li, L., Partyka, K. A., Anderson, M. A., Brenner, D. E., Kaul, K. L., Zeh, H. J., Moser, A. J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029180 · Cited by 81
L-Selectin−Carbohydrate Interactions: Relevant Modifications of the Lewis x Trisaccharide
Sanders, W. J., Katsumoto, T. R., Bertozzi, C. R., Rosen, S. D., & Kiessling, L. L. (1996) · Biochemistry · doi:10.1021/bi9613640 · Cited by 76
Pedersen, J. W., Gentry‐Maharaj, A., Fourkala, E., Dawnay, A., Burnell, M., Zaikin, A. A., Pedersen, A. E., Jacobs, I. J., Menon, U., & Wandall, H. H. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.517 · Cited by 75
Geng, Y., Marshall, J. R., & King, M. R. (2011) · Annals of Biomedical Engineering · doi:10.1007/s10439-011-0463-6 · Cited by 74
Two opposing roles of O-glycans in tumor metastasis
Tsuboi, S., Hatakeyama, S., Οhyama, C., & Fukuda, M. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.02.001 · Cited by 72
MUC1 oncoprotein is a druggable target in human prostate cancer cells
Joshi, M. D., Ahmad, R., Yin, L., Raina, D., Rajabi, H., Bubley, G., Kharbanda, S., & Kufe, D. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0646 · Cited by 72
Characterization of Human Mucin MUC17
Moniaux, N., Junker, W. M., Singh, A. P., Jones, A. M., & Batra, S. K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600302200 · Cited by 71
Self-citationRole of MUC4–NIDO domain in the MUC4-mediated metastasis of pancreatic cancer cells
Senapati, S., Gnanapragassam, V. S., Moniaux, N., Momi, N., & Batra, S. K. (2011) · Oncogene · doi:10.1038/onc.2011.505 · Cited by 71
Self-citationChoudhury, A., Singh, R. K., Moniaux, N., El‐Metwally, T. H., Aubert, J., & Batra, S. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005115200 · Cited by 68
Self-citationJonckheere, N., Skrypek, N., Merlin, J., Dessein, A., Dumont, P., Leteurtre, E., Harris, A., Desseyn, J., Susini, C., Frénois, F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032232 · Cited by 65
Tempero, R. M., VanLith, M. L., Morikane, K., Rowse, G. J., Gendler, S. J., & Hollingsworth, M. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.10.5500 · Cited by 65
Yu, C., Shih, J., Lee, Y.-C., Shun, C., Yuan, A., & Yang, P. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2004.05.018 · Cited by 64
Güleç, S. A., Cohen, S. J., Pennington, K. L., Zuckier, L. S., Hauke, R. J., Horne, H. B., Wegener, W. A., Teoh, N., Gold, D. V., Sharkey, R. M., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2579 · Cited by 63
Carrara, S., Cangi, M. G., Arcidiacono, P. G., Perri, F., Petrone, M. C., Mezzi, G., Boemo, C., Talarico, A., Cin, E. D., Grassini, G., et al. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.22 · Cited by 61
Wang, Y., Gao, J., Li, Z., Jin, Z., Gong, Y.-F., & Man, X. (2007) · International Journal of Cancer · doi:10.1002/ijc.22997 · Cited by 61
Core2 O-glycan-expressing prostate cancer cells are resistant to NK cell immunity
Okamoto, T., Yoneyama, M. S., Hatakeyama, S., Mori, K., Yamamoto, H., Koie, T., Saitoh, H., Yamaya, K., Funyu, T., Fukuda, M., et al. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.1189 · Cited by 57
Transforming Growth Factor α–Dependent Cancer Progression Is Modulated by Muc1
Pochampalli, M. R., Bitler, B. G., & Schroeder, J. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4518 · Cited by 52
Gold, D. V., Gaedcke, J., Ghadimi, Β. M., Goggins, M., Hruban, R. H., Liu, M., Newsome, G., & Goldenberg, D. M. (2012) · Cancer · doi:10.1002/cncr.27762 · Cited by 51
Nissim, S., Idos, G., & Wu, B. U. (2012) · Pancreas · doi:10.1097/mpa.0b013e3182580fb4 · Cited by 50
Cardillo, T. M., Ying, Z., & Gold, D. V. (2001) · PubMed · Cited by 48
Genomic organization of MUC4 mucin gene: Towards the characterization of splice variants
Escande, F., LEMAITRE, L., Moniaux, N., Batra, S. K., Aubert, J., & Buisine, M. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03032.x · Cited by 46
Self-citationThe MUC gene family: their role in the diagnosis and prognosis of gastric cancer.
Senapati, S., Sharma, P., Bafna, S., Roy, H. K., & Batra, S. K. (2008) · PubMed · doi:10.14670/hh-23.1541 · Cited by 44
Self-citationTurner, M. S., Cohen, P., & Finn, O. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2787 · Cited by 44
Fan, X.-N., Karsten, U. R., Goletz, S., & Cao, Y. (2010) · Pathology - Research and Practice · doi:10.1016/j.prp.2010.03.006 · Cited by 44
Lau, S. K. M., Shields, D. J., Murphy, E. A., Desgrosellier, J. S., Anand, S., Huang, M., Kato, S., Lim, S., Weis, S. M., Stupack, D. G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036753 · Cited by 42
Pelaseyed, T., Zäch, M., Petersson, Å. C., Svensson, F. R., Johansson, D. G. A., & Hansson, G. C. (2013) · FEBS Journal · doi:10.1111/febs.12144 · Cited by 41
Alternate splicing at the 3?-end of the human pancreatic tumor-associated mucin MUC4 cDNA
Choudhury, A., Moniaux, N., Ringel, J. O. R., King, J., Moore, E. D., Aubert, J., & Batra, S. K. (2000) · Teratogenesis Carcinogenesis and Mutagenesis · Cited by 39
Self-citationLocalization of pancreatic cancer with radiolabeled monoclonal antibody PAM4
Gold, D. V., Cardillo, T. M., Goldenberg, D. M., & Sharkey, R. M. (2001) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00114-7 · Cited by 37
Ohno, S., Ohno, Y., Nakada, H., Suzuki, N., Soma, G., & Inoue, M. (2006) · PubMed · Cited by 32
Horn, A. J., Chakraborty, S., Dey, P., Haridas, D., Souchek, J. J., Batra, S. K., & Lele, S. M. (2013) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2011-0229-oa · Cited by 31
Self-citationKondo, A., Li, W., Nakagawa, T., Nakano, M., Koyama, N., Wang, X., Gu, J., Miyoshi, E., & Taniguchi, N. (2006) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2006.10.011 · Cited by 27
Shimamoto, T., Tani, M., Kawai, M., Hirono, S., Ina, S., Miyazawa, M., Shimizu, A., Uchiyama, K., Yokoyama, S., Tsutsumi, M., et al. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181d6ba04 · Cited by 26
Andrianifahanana, M., Chauhan, S. C., Choudhury, A., Moniaux, N., Brand, R. E., Sasson, A. A., Pour, P. M., & Batra, S. K. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00871.x · Cited by 15
Self-citationMUC1 is a novel costimulatory molecule of human T cells and functions in an AP-1-dependent manner
Konowalchuk, J. D., & Agrawal, B. (2012) · Human Immunology · doi:10.1016/j.humimm.2012.02.024 · Cited by 13
Cited by
Early Detection of Pancreatic Cancer: Opportunities and Challenges
Singhi, A. D., Koay, E. J., Chari, S. T., & Maitra, A. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.259 · Cited by 841
Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment
Abdol Razak, N., Jones, G., Bhandari, M., Berndt, M., & Metharom, P. (2018) · Cancers · doi:10.3390/cancers10100380 · Cited by 631
Chitosan: A Potential Biopolymer in Drug Delivery and Biomedical Applications
Desai, N., Rana, D., Salave, S., Gupta, R., Patel, P., Karunakaran, B., Sharma, A., Giri, J., Benival, D., & Kommineni, N. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041313 · Cited by 628
The tumour glyco-code as a novel immune checkpoint for immunotherapy
RodrÍguez, E., Schetters, S. T. T., & van Kooyk, Y. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2018.3 · Cited by 473
Altered Tumor-Cell Glycosylation Promotes Metastasis
Häuselmann, I., & Borsig, L. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00028 · Cited by 382
Metadata
- Authors
- Kaur, S., Kumar, S., Momi, N., Sasson, A. R., & Batra, S. K.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2013-07-16
- Volume
- 10
- Issue
- 10
- Pages
- 607-620
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W2076211055
- Cited by
- 301
- References
- 123
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.